Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Davita Inc (DVA) – Davita Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

DaVita (DVA) trades at $198.65, up 1.21% on the day, near its consensus price target of $213.50. The stock shows bullish momentum with strong Q1 2026 earnings beating estimates, revenue growth of 6% year-over-year, and raised annual guidance. Technical indicators are mixed with moving averages bullish but RSI levels suggesting overbought conditions. Recent news highlights robust dialysis demand and margin expansion as key drivers.
Outlook remains positive with mid-teens EPS growth expected through 2026, supported by steady demand and operational efficiency. Risks include high debt levels and reliance on healthcare reimbursement policies. Analyst consensus is cautiously optimistic with 39% buy ratings, but investors should monitor execution against guidance and debt management.
Read full analysis

Key Stats

  • Market Cap
    $12.75B
  • Sector
    Health
  • 3M Drawdown
    -7.78%
  • Enterprise Value
    $25.30B
  • Dividend Yield
    -
  • Trading Activity
    90% Buy | 10% Sell
  • Typical Hold Time
    100 days
$195.79
52W Low: $103.87
14 Jan 2026
52W High: $198.65
08 May 2026

Davita Inc (DVA) is currently valued at a market capitalization of $12.75B, with an enterprise value of $25.30B. Over the past 52 weeks, Davita Inc has traded between a low of $103.87 and a high of $198.65, highlighting its annual price range. Over the past three months, Davita Inc has recorded a drawdown of -7.78%, reflecting recent price volatility. On average, investors hold Davita Inc for approximately 100 days, indicating typical investor behavior on the platform.

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.


Technical Indicators
|
|
|
Overall Summary
Bearish (3)Neutral (11)Bullish (13)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $12.75B
  • Sector
    Health
  • 3M Drawdown
    -7.78%
  • Enterprise Value
    $25.30B
  • Dividend Yield
    -
  • Trading Activity
    90% Buy | 10% Sell
  • Typical Hold Time
    100 days
$195.79
52W Low: $103.87
14 Jan 2026
52W High: $198.65
08 May 2026

Davita Inc (DVA) is currently valued at a market capitalization of $12.75B, with an enterprise value of $25.30B. Over the past 52 weeks, Davita Inc has traded between a low of $103.87 and a high of $198.65, highlighting its annual price range. Over the past three months, Davita Inc has recorded a drawdown of -7.78%, reflecting recent price volatility. On average, investors hold Davita Inc for approximately 100 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!